v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows used in operating activities:    
Net loss $ (17,403,586) $ (1,596,513)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation issued for services 142,450
Stock compensation issued to directors and employees 92
Fair value of stock options issued to employees 70,655 71,301
Non-cash compensation for services 45,000 45,000
Amortization of discount on notes payable 87,055 98,038
Gain from equity method investment (15,096) (104)
Impairment loss 14,645,069
Loss from disposal of assets 561,663
Gain on lease termination (94,551)
Depreciation and amortization 234,462 226,960
Changes in assets and liabilities:    
Accounts receivable 1,267 (36,338)
Inventory 3,306 (1,947)
Prepaid expenses and other current assets (156,353) (330,104)
Accounts payable and accrued expenses (934,839) 472,106
Accrued compensation (256,689) 43,968
Deferred revenue 122,971 104,656
Leasehold liability 4,884 2,323
Accrued interest 6,360 30,443
Net cash used in operating activities (3,545,534) (260,557)
Cash used in investing activities:    
Payments to acquire property, plant, and equipment (14,650) (49,698)
Proceeds from sale of fixed assets 25,590
Net cash used in investing activities (14,650) (24,108)
Cash from financing activities:    
Proceeds from the sale of notes payable 225,000
Proceeds from the sale of common stock, net of offering costs 8,747,902
Proceeds from sale of preferred stock 500,000
Proceeds from warrant exercise 88
Preferred stock redemption (4,000,000)
Principal payments on notes payable (1,088,795) (197,634)
Net cash provided by financing activities 3,659,195 527,366
Increase in cash and cash equivalents 99,011 242,701
Cash and cash equivalents at beginning of period 741,396 232,424
Cash and cash equivalents at end of period 840,407 475,125
Supplemental disclosure of cash flow information:    
Interest 169,042 50,804
Noncash activities:    
Accrued dividends on preferred stock 305,245
Preferred stock redemption adjustment $ 521,922